Compare Stocks Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities. Stocks to Compare Sections All Sections Selected Performance Chart Price & Volume MarketRank Analyst Ratings Sales & Book Value Profitability & Earnings Dividends Debt Ownership Miscellaneous Headlines About Compare NASDAQ:APYXNASDAQ:BSGMNASDAQ:ECORNASDAQ:TELA On This Page Performance ChartPrice & VolumeMarketRank™Analyst RatingsSales & Book ValueProfitability & EarningsDividendsDebtOwnershipMiscellaneousHeadlinesAbout Comparison Ideas Stock Ideas Comparative Price Performance Over Time1 day7 days30 days90 days365 daysCompare Price & VolumeCompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's VolumeAPYXApyx Medical$0.98+5.2%$1.21$0.76▼$1.99$37.91M0.9249,141 shs92,639 shsBSGMBioSig Technologies$0.58$0.72$0.20▼$2.57$10.00M0.79230,921 shs113,076 shsECORelectroCore$6.09+1.8%$10.98$5.02▼$19.49$43.77M0.8377,176 shs47,187 shsTELATELA Bio$0.97+0.8%$1.93$0.86▼$6.50$38.25M0.98227,980 shs20,851 shs20 High-Yield Dividend Stocks that Could Ruin Your RetirementAlmost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.Get This Free ReportCompare Price PerformanceCompany1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year PerformanceAPYXApyx Medical-8.82%+3.33%-17.70%-34.51%-33.09%BSGMBioSig Technologies-1.69%-7.94%-15.20%-50.85%-61.59%ECORelectroCore-3.70%+2.93%-27.60%-61.91%+8.53%TELATELA Bio-4.29%-7.08%-60.61%-64.02%-80.74%Remove AdsCompare MarketRank™CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & ValuationAPYXApyx Medical2.0549 of 5 stars0.03.00.04.23.81.70.6BSGMBioSig Technologies1.91 of 5 stars3.50.00.00.02.60.80.6ECORelectroCore3.3807 of 5 stars3.55.00.00.03.32.50.6TELATELA Bio2.0296 of 5 stars3.43.00.00.01.31.70.6Compare Analyst ForecastsCompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current PriceAPYXApyx Medical 2.67Moderate BuyN/AN/ABSGMBioSig Technologies 3.00Buy$2.75366.10% UpsideECORelectroCore 3.00Buy$25.50339.73% UpsideTELATELA Bio 2.75Moderate Buy$7.25647.42% UpsideCurrent Analyst Ratings BreakdownLatest BSGM, ECOR, APYX, and TELA Analyst RatingsDateCompanyBrokerageActionRatingPrice TargetDetails3/21/2025TELATELA BioCanaccord Genuity GroupSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$12.00 ➝ $7.003/21/2025TELATELA BioPiper SandlerSubscribe to MarketBeat All Access for the recommendation accuracy ratingDowngradeOverweight ➝ Neutral$5.00 ➝ $2.003/13/2025ECORelectroCoreLADENBURG THALM/SH SHSubscribe to MarketBeat All Access for the recommendation accuracy ratingLower Price TargetBuy ➝ Buy$28.00 ➝ $26.003/13/2025ECORelectroCoreHC WainwrightSubscribe to MarketBeat All Access for the recommendation accuracy ratingReiterated RatingBuy ➝ Buy$25.00 ➝ $25.00(Data available from 4/17/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)Compare Sales & Book ValueCompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/BookAPYXApyx Medical$48.10M0.75N/AN/A$0.78 per share1.22BSGMBioSig Technologies$39K260.73N/AN/A($0.33) per share-1.79ECORelectroCore$25.18M1.66N/AN/A$1.24 per share4.68TELATELA Bio$69.30M0.55N/AN/A$0.77 per share1.26Compare Profitability & EarningsCompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings DateAPYXApyx Medical-$18.71M-$0.67N/AN/AN/A-58.59%-137.98%-36.74%5/8/2025 (Estimated)BSGMBioSig Technologies-$29.04MN/A0.00N/AN/A-44,832.50%N/A-776.49%5/19/2025 (Estimated)ECORelectroCore-$18.83M-$1.62N/AN/AN/A-54.40%-154.45%-69.16%5/6/2025 (Estimated)TELATELA Bio-$46.66M-$1.39N/AN/AN/A-60.49%-556.18%-63.13%5/8/2025 (Estimated)Latest BSGM, ECOR, APYX, and TELA EarningsDateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails5/14/2025Q1 2025ECORelectroCore-$0.56N/AN/AN/AN/AN/A5/8/2025Q1 2025APYXApyx Medical-$0.13N/AN/AN/A$9.39 millionN/A5/8/2025Q1 2025TELATELA Bio-$0.21N/AN/AN/A$17.35 millionN/A3/20/2025Q4 2024TELATELA Bio-$0.24-$0.23+$0.01-$0.23$23.17 million$17.65 million3/13/2025Q4 2024APYXApyx Medical-$0.13-$0.12+$0.01-$0.12$13.39 million$14.22 millionCompare DividendsCompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive GrowthAPYXApyx MedicalN/AN/AN/AN/AN/ABSGMBioSig TechnologiesN/AN/AN/AN/AN/AECORelectroCoreN/AN/AN/AN/AN/ATELATELA BioN/AN/AN/AN/AN/ACompare DebtCompanyDebt-to-Equity RatioCurrent RatioQuick RatioAPYXApyx Medical3.035.464.52BSGMBioSig TechnologiesN/A0.500.50ECORelectroCoreN/A2.121.87TELATELA Bio14.222.621.81Compare OwnershipInstitutional OwnershipCompanyInstitutional OwnershipAPYXApyx Medical55.33%BSGMBioSig Technologies7.16%ECORelectroCore26.74%TELATELA Bio94.35%Insider OwnershipCompanyInsider OwnershipAPYXApyx Medical16.80%BSGMBioSig Technologies17.03%ECORelectroCore19.70%TELATELA Bio6.00%Compare Miscellaneous StatsCompanyEmployeesShares OutstandingFree FloatOptionableAPYXApyx Medical27037.79 million31.32 millionOptionableBSGMBioSig Technologies5017.24 million14.30 millionNo DataECORelectroCore507.19 million5.35 millionNot OptionableTELATELA Bio12039.39 million37.03 millionOptionableBSGM, ECOR, APYX, and TELA HeadlinesRecent News About These CompaniesCanaccord Genuity Keeps Their Buy Rating on TELA Bio (TELA)April 9, 2025 | markets.businessinsider.comTELA Bio launches larger sizes of OviTex PRS for plastic and reconstructive surgeryApril 2, 2025 | pharmabiz.comTELA Bio Expands OviTex PRS Line with Larger Surgical SizesApril 2, 2025 | msn.comTela Bio announces U.S. launch of larger sizes of OviTex PRSApril 1, 2025 | markets.businessinsider.comTELA Bio Announces U.S. Commercial Launch of Larger Sizes of OviTex® PRS for Plastic and Reconstructive SurgeryApril 1, 2025 | markets.businessinsider.comPerkins Capital Management Inc. Has $2.74 Million Holdings in TELA Bio, Inc. (NASDAQ:TELA)March 25, 2025 | marketbeat.comTELA BIO Earnings Results: $TELA Reports Quarterly EarningsMarch 23, 2025 | nasdaq.comTELA Bio Full Year 2024 Earnings: Revenues DisappointMarch 23, 2025 | finance.yahoo.comCanaccord Genuity Group Lowers TELA Bio (NASDAQ:TELA) Price Target to $7.00March 22, 2025 | marketbeat.comTELA Bio, Inc. (NASDAQ:TELA) Q4 2024 Earnings Call TranscriptMarch 22, 2025 | insidermonkey.comTELA Bio (NASDAQ:TELA) Rating Lowered to Neutral at Piper SandlerMarch 22, 2025 | marketbeat.comTELA Bio, Inc.: TELA Bio Reports Fourth Quarter and Full Year 2024 Financial ResultsMarch 21, 2025 | finanznachrichten.deTela Bio price target lowered to $7 from $12 at Citizens JMPMarch 21, 2025 | markets.businessinsider.comTela Bio downgraded to Neutral from Overweight at Piper SandlerMarch 21, 2025 | markets.businessinsider.comTELA Bio Shares Drop 43% After Weak Q4 Growth, High Sales TurnoverMarch 21, 2025 | finance.yahoo.comTela Bio slumps after Q4 miss as Piper Sandler downgradesMarch 21, 2025 | msn.comTELA Bio’s Earnings Call: Challenges and Optimism for 2025March 21, 2025 | tipranks.comTELA Bio (NASDAQ:TELA) Releases Earnings Results, Beats Estimates By $0.01 EPSMarch 21, 2025 | marketbeat.comTela Bio sees Q1 revenue $17M-$18M, consensus $21.05MMarch 21, 2025 | markets.businessinsider.comTELA Bio shares plunge on Q4 revenue miss, weak guidanceMarch 21, 2025 | investing.comTELA Bio sees 23-27% revenue growth for 2025 with expanded sales strategyMarch 21, 2025 | msn.comNew MarketBeat Followers Over TimeMedia Sentiment Over TimeTop HeadlinesView All HeadlinesBYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?By Jeffrey Neal Johnson | March 21, 2025View BYD Unveils Ultra-Fast Charging—Will It Supercharge BYDDY Stock?Are Tariffs Threatening Disney’s Comeback Story?By Jea Yu | April 9, 2025View Are Tariffs Threatening Disney’s Comeback Story?Micron Stock Will Retest All-Time Highs This YearBy Thomas Hughes | March 21, 2025View Micron Stock Will Retest All-Time Highs This YearEnergy Transfer: Tariff-Resistant Midstream Resilience By Jeffrey Neal Johnson | April 11, 2025View Energy Transfer: Tariff-Resistant Midstream Resilience Get Paid With Paychex: Dividends and Higher Prices TooBy Thomas Hughes | March 31, 2025View Get Paid With Paychex: Dividends and Higher Prices TooBSGM, ECOR, APYX, and TELA Company DescriptionsApyx Medical NASDAQ:APYX$0.98 +0.05 (+5.16%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.Apyx Medical Corporation, an energy technology company, engages in the design, development, and manufacture of medical devices in the United States and internationally. The company operates through two segments: Advanced Energy and Original Equipment Manufacturing (OEM). It offers Helium Plasma Generator for delivery of RF energy and helium plasma to cut, coagulate, and ablate soft tissue during open and minimally invasive surgical procedures. The company's Helium Plasma Technology products are marketed and sold under the Renuvion name in the cosmetic surgery market and under the J-Plasma name in the hospital surgical market. It also develops and manufactures various hand pieces for open and laparoscopic procedures; and OEM generators, as well as related accessories. The company was formerly known as Bovie Medical Corporation and changed its name to Apyx Medical Corporation in January 2019. Apyx Medical Corporation was incorporated in 1982 and is based in Clearwater, Florida.BioSig Technologies NASDAQ:BSGM$0.58 0.00 (0.00%) As of 03:32 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.BioSig Technologies, Inc., together with its subsidiaries, a medical device company, engages in development and commercialization of advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias in the United States. It offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. The company has a research agreement with Mayo Foundation to develop an AI- and machine learning-powered software for PURE EP system. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.electroCore NASDAQ:ECOR$6.08 +0.11 (+1.76%) As of 03:35 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.electroCore, Inc., a commercial stage bioelectronic medicine and wellness company, provides non-invasive vagus nerve stimulation technology platform in the United States, the United Kingdom, and internationally. The company is developing gammaCore, a prescription only handheld device intended for regular or intermittent use for the acute treatment of pain associated with migraine and episodic cluster headache, as well as for the treatment of hemicrania continua and paroxysmal hemicrania. It also develops Truvaga for the support of general health and wellbeing; and TAC-STIM for human performance. In addition, the company offers gammacore Sapphire, a portable, reusable, rechargeable, and reloadable prescription medical device for various primary headache conditions. electroCore, Inc. was incorporated in 2005 and is headquartered in Rockaway, New Jersey.TELA Bio NASDAQ:TELA$0.96 +0.01 (+0.83%) As of 03:40 PM Eastern This is a fair market value price provided by Polygon.io. Learn more.TELA Bio, Inc., a commercial-stage medical technology company, focuses on providing soft-tissue reconstruction solutions that optimize clinical outcomes by prioritizing the preservation and restoration of the patient's anatomy. The company provides a portfolio of OviTex Reinforced Tissue Matrix (OviTex) products for hernia repair and abdominal wall reconstruction; and OviTex PRS Reinforced Tissue Matrix products to address the unmet needs in plastic and reconstructive surgery, as well as OviTex for Laparoscopic and Robotic Procedures, a sterile reinforced tissue matrix derived from ovine rumen with polypropylene fiber intended to be used in laparoscopic and robotic-assisted hernia surgical repairs. It markets its products through a single direct sales force, principally in the United States. The company was incorporated in 2012 and is headquartered in Malvern, Pennsylvania. More Stock Comparisions from MarketBeat Stock Comparison Ideas (A-K)5GAgricultureAirlineAmerica FirstApparelArtificial IntelligenceAutomotiveBankBiotechBitcoinBlockchainBlue ChipCanadianCannabisCasinoChatGPTChineseCloud StorageCryptocurrencyCybersecurityDefenseDividendDow 30EcommerceElectric VehiclesEnergyEntertainmenteSportsEV ChargingFertilizerGoldGroceryGrowthHealthcareHigh DividendHotelStock Comparison Ideas (L-Z)Large CapLeisureLithiumMagnificent SevenMega CapMemeMetaverseMid CapMiningMusic IndustryNanotechnologyNFTNuclear EnergyOilPharmaceuticalQuantum ComputingRenewable EnergyRestaurantRetailSemiconductorSocial MediaSolarSpaceTechnologyTelecomToyUtilityVideo GameVirtual RealityWallStreetBets More Stock Ideas from MarketBeat Stock Lists 5G Stocks Biotech Stocks Blue Chip Stocks DOW 30 Stocks FAANG Stocks Gold Stocks Large Cap Stocks Lumber Stocks Marijuana Stocks Micro Cap Stocks Oil Stocks REITs Small Cap Stocks SPACs Travel Stocks Trillion Dollar Stocks Water Stocks Warren Buffett Stocks Low Priced Stocks Penny Stock List Popular Penny Stocks Top Stocks Today Stocks on Sale Stocks Under $0.05 Stocks Under $0.10 Stocks Under $0.25 Stocks Under $0.50 Stocks Under $1 Stocks Under $2 Stocks Under $3 Stocks Under $5 Stocks Under $10 Stocks Under $20 Stocks Under $30 Stocks Under $50 Stocks By Exchange NASDAQ Stocks NYSE Stocks NYSEAMERICAN Stocks NYSEARCA Stocks NYSEMKT Stocks OTCMKTS Stocks TSX Stocks TSXV Stocks LSE Stocks BATS Stocks Latest Stock Ideas Tariff Exemptions Set the Stage for a Taiwan Semiconductor Rally Rocket Lab's Growth Potential Gains Altitude on Defense News Broadcom’s Apple Relationship: AI Opportunity Meets Tariff Risk Tariff-Resistant Abbott Laboratories on Track for New Highs Goldman Sachs Just Revealed What’s Next for Markets United Airlines Is in Reversal—If the Economy Doesn’t Stall Buy the Boeing Dip Even on Tariff and Bans? Spotify Stock Climbs as Its Growth Strategy Diversifies Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
